In prostate cancer cell lines, CXCL16 induced the expression of progangiogenic cytokines IL-8 and VEGF, while CXCR6 expression on implanted tumor cells lead to increased blood vessel formation in mice [36]. The gene discussed is CXCR6; the disease is prostate carcinoma.